Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

National Physical Laboratory collaboration

17 Jun 2019 07:00

RNS Number : 3924C
Haydale Graphene Industries PLC
17 June 2019
 

 

For immediate release

17 June 2019

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

National Physical Laboratory and Haydale collaborate on enhanced functionalisation process

 

Haydale, (AIM: HAYD), the global advanced materials group, has commenced a 12 month Innovate UK project, under the Analysis for Innovators (A4i) scheme, for further investigation of its enhanced functionalisation processes with the National Physical Laboratory (NPL).

In 2014, NPL verified that Haydale's global patented functionalisation process was increasing the quantity of functional groups present on graphitic material. Since then, Haydale has significantly optimised its HDPlas® plasma technology and has substantially increased the surface chemistry present. This gives Haydale the potential to offer a competitive product to graphene oxide that is environmentally friendly and cost competitive as well as an enhanced dispersion capability.

Haydale's technology has shown that it can change the surface characteristics of graphene through its plasma process and vary the level of functionalisation. Through working with NPL, it will now gain a further understanding of the surface chemistry of the graphene after plasma functionalisation. This will allow an accurate tailoring of plasma functionalisation parameters to vary the concentration of functional groups, and therefore further enhance the benefits of the functionalised nanomaterial in Haydale's key market applications of inks, elastomers, coatings and composites. This will lead to added reliability for customers, improved material data and, fundamentally, improved time to market

Keith Broadbent, Haydale CEO, said: "This world-class research and analysis is imperative for the development and understanding of our functionalisation process. Customers will directly benefit from the results as they work with certified materials."

David Banks, Haydale Chairman, said: "This grant offers access to expert knowledge and world-class analytical facilities to allow Haydale to continue with its focused product development & certification. We look forward to working with NPL and further developing our functionalisation process."

Andrew Pollard, NPL Science Area Leader, said: "Understanding the fundamental material properties of graphene after industrial processing steps, is crucial in determining the performance-enhancement in real-world products. We look forward to collaborating with Haydale on their graphene functionalisation process."

- Ends -

 

For further information:

 

Haydale Graphene Industries plc

 

Keith Broadbent, Haydale CEO

Tel: +44 (0) 1269 842 946

Gemma Smith, Head of Marketing

www.haydale.com 

 

Arden Partners plc (Nominated Adviser & Broker)

Ruari McGirr / Paul Shackleton / Ben Cryer

 

 

Tel: +44 (0) 20 7614 5900

 

 

 

 

Notes to Editors

About Haydale:

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 

 

About NPL:

 

NPL is the UK's National Measurement Institute, providing the measurement capability that underpins the UK's prosperity and quality of life.

From new antibiotics to tackle resistance and more effective cancer treatments, to unhackable quantum communications and superfast 5G, technological advances must be built on a foundation of reliable measurement to succeed. Building on over a century's worth of expertise, our science, engineering and technology provides this foundation. We save lives, protect the environment and enable citizens to feel safe and secure, as well as support international trade and commercial innovation. As a national laboratory, our advice is always impartial and independent, meaning consumers, investors, policymakers and entrepreneurs can always rely on the work we do.

Based in Teddington, south-west London, NPL employs over 500 scientists and is home to 388 of the world's most extensive and sophisticated laboratories. NPL also has regional bases across the UK, including at the University of Surrey, the University of Strathclyde, the University of Cambridge and the University of Huddersfield's 3M Buckley Innovation Centre.

For more information please visit: www.npl.co.uk

Twitter: @NPL

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRACKADNOBKDOAD
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.